Calls
1
u/itzmonsterz
Reddit r/wallstreetbets
Win Rate
0.0%
return
-25.1%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 16
$4.74
-25.1%
The author claims Recursion Pharmaceuticals is a high-upside TechBio play with a proprietary 23+ petabyte biological dataset and NVIDIA partnership, validated by Roche/Genentech and Bayer partnerships. Strong Phase 1b/2 TUPELO data for REC-4881 and expected FDA engagement in 1H 2026 are concrete catalysts to re-rate the stock. High short interest over 20% of float could trigger a squeeze on positive news. Main risks are clinical trial failure and high-rate/risk-off sentiment hitting small-cap growth.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/itzmonsterz has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: RXRX.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
